Survey Results About the Impact of Coronavirus One Year on

Our panel members shared their thoughts about the impact of the pandemic. Over 1500 healthcare professionals and patients took part of our study.
Which (if any) of the measures adopted over the past year do you think will be considered normal going forward?

For over 80% of both the general public and healthcare professionals, ‘more frequent hand washing’ is considered to be the most enduring change post-COVID, which is unsurprising given the massive reduction in rates of seasonal influenza and norovirus during the winter of 2020-21. By contrast, only 43% of the general public think that remote healthcare consultations are here to stay, compared to 59% of healthcare professionals who will be more acutely aware of the challenges and opportunities virtual appointments represent.

Are you worried that new strains will continue to evolve and render the current range of available vaccines obsolete?

Across both the general public and healthcare professional populations there is an equally high degree of concern, with 65% or respondents worried that current vaccines won’t be futureproof in the face of new strains of COVID-19. British and German respondents are least concerned, at 54% and 56% respectively, but by contrast, 72% Italian respondents, and 79% Spanish respondents are the most worried.

How has the pandemic affected your mental health?

75% of HCP respondents felt that the pandemic had impacted their mental health, to varying degrees. 34% reported that their mental health had been moderately or severely affected, with the majority (41%) responding that their mental health had only been…

Read the full article

Register to M3 to get full access and take part in paid healthcare market research

M3 Member? Login to your account to read the full article

Read the full article


  1. I’m very worried about new strains and the old strain too. In remission with lymphoma, had both shots of Moderna. Test shows no anti-bodies in me. My immune is still low too.

    1. Si nota anche un abbassamento anticorpale nei pz con gruppi sanguigni diversi.
      Il titolo si mantiene più alto nei gruppi A

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.